Study of Environmental Enteropathy and Malnutrition (SEEM) in Pakistan: protocols for biopsy based biomarker discovery and validation.
Childhood undernutrition
Duodenal biopsies
Endoscopy
Environmental enteropathy
Gut barrier function
Low- middle income countries
Mucosal gene expression
Small intestinal microbiota
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
22 07 2019
22 07 2019
Historique:
received:
02
10
2018
accepted:
31
05
2019
entrez:
24
7
2019
pubmed:
25
7
2019
medline:
10
10
2020
Statut:
epublish
Résumé
Environmental Enteropathy (EE), characterized by alterations in intestinal structure, function, and immune activation, is believed to be an important contributor to childhood undernutrition and its associated morbidities, including stunting. Half of all global deaths in children < 5 years are attributable to under-nutrition, making the study of EE an area of critical priority. Community based intervention study, divided into two sub-studies, 1) Longitudinal analyses and 2) Biopsy studies for identification of EE features via omics analyses. Birth cohorts in Matiari, Pakistan established: moderately or severely malnourished (weight for height Z score (WHZ) < - 2) children, and well-nourished (WHZ > 0) children. Blood, urine, and fecal samples, for evaluation of potential biomarkers, will be collected at various time points from all participants (longitudinal analyses). Participants will receive appropriate educational and nutritional interventions; non-responders will undergo further evaluation to determine eligibility for further workup, including upper gastrointestinal endoscopy. Histopathological changes in duodenal biopsies will be compared with duodenal biopsies obtained from USA controls who have celiac disease, Crohn's disease, or who were found to have normal histopathology. RNA-Seq will be employed to characterize mucosal gene expression across groups. Duodenal biopsies, luminal aspirates from the duodenum, and fecal samples will be analyzed to define microbial community composition (omic analyses). The relationship between histopathology, mucosal gene expression, and community configuration will be assessed using a variety of bioinformatic tools to gain better understanding of disease pathogenesis and to identify mechanism-based biomarkers. Ethical review committees at all collaborating institutions have approved this study. All results will be made available to the scientific community. Operational and ethical constraints for safely obtaining intestinal biopsies from children in resource-poor settings have led to a paucity of human tissue-based investigations to understand and reverse EE in vulnerable populations. Furthermore, EE biomarkers have rarely been correlated with gold standard histopathological confirmation. The Study of Environmental Enteropathy and Malnutrition (SEEM) is designed to better understand the pathophysiology, predictors, biomarkers, and potential management strategies of EE to inform strategies to eradicate this debilitating pathology and accelerate progress towards the 2030 Sustainable Development Goals. Retrospectively registered; clinicaltrials.gov ID NCT03588013 .
Sections du résumé
BACKGROUND
Environmental Enteropathy (EE), characterized by alterations in intestinal structure, function, and immune activation, is believed to be an important contributor to childhood undernutrition and its associated morbidities, including stunting. Half of all global deaths in children < 5 years are attributable to under-nutrition, making the study of EE an area of critical priority.
METHODS
Community based intervention study, divided into two sub-studies, 1) Longitudinal analyses and 2) Biopsy studies for identification of EE features via omics analyses. Birth cohorts in Matiari, Pakistan established: moderately or severely malnourished (weight for height Z score (WHZ) < - 2) children, and well-nourished (WHZ > 0) children. Blood, urine, and fecal samples, for evaluation of potential biomarkers, will be collected at various time points from all participants (longitudinal analyses). Participants will receive appropriate educational and nutritional interventions; non-responders will undergo further evaluation to determine eligibility for further workup, including upper gastrointestinal endoscopy. Histopathological changes in duodenal biopsies will be compared with duodenal biopsies obtained from USA controls who have celiac disease, Crohn's disease, or who were found to have normal histopathology. RNA-Seq will be employed to characterize mucosal gene expression across groups. Duodenal biopsies, luminal aspirates from the duodenum, and fecal samples will be analyzed to define microbial community composition (omic analyses). The relationship between histopathology, mucosal gene expression, and community configuration will be assessed using a variety of bioinformatic tools to gain better understanding of disease pathogenesis and to identify mechanism-based biomarkers. Ethical review committees at all collaborating institutions have approved this study. All results will be made available to the scientific community.
DISCUSSION
Operational and ethical constraints for safely obtaining intestinal biopsies from children in resource-poor settings have led to a paucity of human tissue-based investigations to understand and reverse EE in vulnerable populations. Furthermore, EE biomarkers have rarely been correlated with gold standard histopathological confirmation. The Study of Environmental Enteropathy and Malnutrition (SEEM) is designed to better understand the pathophysiology, predictors, biomarkers, and potential management strategies of EE to inform strategies to eradicate this debilitating pathology and accelerate progress towards the 2030 Sustainable Development Goals.
TRIAL REGISTRATION
Retrospectively registered; clinicaltrials.gov ID NCT03588013 .
Identifiants
pubmed: 31331393
doi: 10.1186/s12887-019-1564-x
pii: 10.1186/s12887-019-1564-x
pmc: PMC6643315
doi:
Substances chimiques
Biomarkers
0
Banques de données
ClinicalTrials.gov
['NCT03588013']
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
247Subventions
Organisme : FIC NIH HHS
ID : K43 TW010697
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK078392
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI116491
Pays : United States
Références
Eur J Clin Invest. 1999 Feb;29(2):160-5
pubmed: 10093003
J Infect Dis. 2000 Sep;182 Suppl 1:S23-8
pubmed: 10944481
Br J Nutr. 2002 Aug;88(2):141-9
pubmed: 12171055
J Nutr. 2003 May;133(5):1237
pubmed: 12730402
J Nutr. 2003 May;133(5):1332-8
pubmed: 12730419
Pediatr Res. 2003 Sep;54(3):306-11
pubmed: 12788978
J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):153-7
pubmed: 15269619
Am J Clin Nutr. 2005 Nov;82(5):1040-5
pubmed: 16280436
Postgrad Med J. 2006 Dec;82(974):779-87
pubmed: 17148698
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
J Pediatr Gastroenterol Nutr. 1991 Feb;12(2):195-203
pubmed: 1904932
Am J Clin Nutr. 2009 Feb;89(2):592-600
pubmed: 19116330
Nat Biotechnol. 2009 May;27(5):455-7
pubmed: 19430453
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W305-11
pubmed: 19465376
Am J Gastroenterol. 2009 Sep;104(9):2326-33
pubmed: 19491826
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W96-102
pubmed: 20484371
Pediatr Res. 2011 Jun;69(6):530-7
pubmed: 21378598
PLoS One. 2012;7(2):e30791
pubmed: 22319588
Trends Mol Med. 2012 Jun;18(6):328-36
pubmed: 22633998
Nature. 2012 May 09;486(7402):222-7
pubmed: 22699611
J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):747-50
pubmed: 22732897
Clin Nutr. 2013 Apr;32(2):245-51
pubmed: 22892368
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
Nat Methods. 2012 Nov;9(11):1069-76
pubmed: 23132118
Nat Methods. 2013 Jan;10(1):71-3
pubmed: 23160280
Am J Clin Nutr. 2013 May;97(5):1129-33
pubmed: 23553156
J Hum Nutr Diet. 2014 Apr;27 Suppl 2:57-64
pubmed: 23647171
J Comput Biol. 2013 Dec;20(12):970-8
pubmed: 23961961
Cell Host Microbe. 2014 Mar 12;15(3):382-392
pubmed: 24629344
N Engl J Med. 2014 Apr 3;370(14):1287-97
pubmed: 24645800
PLoS One. 2014 Apr 14;9(4):e94863
pubmed: 24733310
Nature. 2014 Jun 19;510(7505):417-21
pubmed: 24896187
J Clin Invest. 2014 Aug;124(8):3617-33
pubmed: 25003194
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S213-9
pubmed: 25305289
J Nutr. 2014 Dec;144(12):2059-65
pubmed: 25411039
Cell. 2014 Nov 6;159(4):789-99
pubmed: 25417156
Sci Transl Med. 2015 Feb 25;7(276):276ra24
pubmed: 25717097
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
Genome Biol. 2015 Sep 30;16:211
pubmed: 26420038
EBioMedicine. 2015 Sep 25;2(11):1759-66
pubmed: 26870801
Science. 2016 Feb 19;351(6275):null
pubmed: 26912898
J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):6-14
pubmed: 26974416
J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):156-65
pubmed: 27035374
Am J Trop Med Hyg. 2016 Sep 7;95(3):694-701
pubmed: 27352872
J Pediatr. 2016 Nov;178:7-8
pubmed: 27546205
PLoS One. 2016 Sep 30;11(9):e0158772
pubmed: 27690129
Horm Res Paediatr. 2017;88(1):79-90
pubmed: 28196362
Cell Mol Gastroenterol Hepatol. 2017 Jan 14;3(2):150-162
pubmed: 28275682
Lancet. 1986 Nov 22;2(8517):1183-5
pubmed: 2877326
BMJ Open. 2017 Aug 11;7(8):e017768
pubmed: 28801442
Sci Rep. 2017 Sep 7;7(1):10888
pubmed: 28883476
PLoS Negl Trop Dis. 2018 Feb 7;12(2):e0006224
pubmed: 29415065
Sci Rep. 2018 Feb 14;8(1):2966
pubmed: 29445110
PLoS One. 2018 Mar 6;13(3):e0193768
pubmed: 29509790
JAMA. 2018 Apr 3;319(13):1317-1318
pubmed: 29532063
J Vis Exp. 2018 Mar 19;(133):
pubmed: 29608151
Am J Trop Med Hyg. 2018 Jun;98(6):1577-1584
pubmed: 29611507
Am J Clin Nutr. 1972 Oct;25(10):1062-6
pubmed: 4627873
J Pathol. 1969 Jun;98(2):146-51
pubmed: 5352370
Ann Intern Med. 1971 Feb;74(2):218-22
pubmed: 5545229
J Am Coll Nutr. 1994 Feb;13(1):51-6
pubmed: 8157854